Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Related Party Transactions (Details Textual)

v3.24.3
Note 6 - Related Party Transactions (Details Textual)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2024
USD ($)
Tactic Pharma, LLC [Member]    
Related Party Transaction, Amounts of Transaction $ 0 $ 0
Tactic Pharma, LLC [Member] | Monopar Therapeutics [Member]    
Equity Method Investment, Ownership Percentage 24.30% 24.30%